# US 2003/0068831 A1 · Proteins and druggable regions of proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0068831 A1
- Document ID: US20030068831A1
- Status: Published application
- Kind: A1
- Application number: 10/097,125
- Filed: 2002-03-12
- Published: 2003-04-10
- Earliest claimed: 2001-03-12
- Inventors: Aled Edwards; Cheryl Arrowsmith; Jack Greenblatt; John D. Mendlein
- Web page: https://patentgrep.com/patent/US20030068831A1

## CPC

- C07K 14/195: from bacteria
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- G01N 33/6803: {General methods of protein analysis not limited to specific proteins or families of proteins}
- G01N 33/6878: {in epitope analysis}
- C07K 2299/00: Coordinates from 3D structures of peptides, e.g. proteins or enzymes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to methods for learning structural information about a molecule or molecular complex. The invention also provides methods for identifying a compound that binds to a molecule or molecular complex. The invention also provides methods for identifying a compound that binds to one molecule or molecular complex and not to one or more other molecules or molecular complexes. Other methods that are provided can be used to identify a compound that binds to at least two molecules or molecular complexes.

## Claims

### Claim 1

A method for determining three dimensional structure information of a protein, the method comprising:
(a) subjecting the protein to analysis by mass spectrometry to identify the protein; and
(b) subjecting the protein to structural characterization using one or more of the following:
(i) NMR spectroscopic analysis; and
(ii) X-ray diffraction analysis of a crystal of the protein.

### Claim 2 (depends on 1)

The method of claim 1, wherein the protein is bacterial in origin.

### Claim 3 (depends on 1)

The method of claim 1, wherein the protein is subjected to NMR spectroscopic analysis and a crystal of the protein is subjected to X-ray diffraction analysis.

### Claim 4 (depends on 1)

The method of claim 1, which further comprises subjecting the protein to proteolytic digestion prior to analysis by mass spectrometry.

### Claim 5 (depends on 1)

The method of claim 1, wherein the mass spectrometry analysis is used to determine the primary sequence of the protein, the type and location of post translational modifications of the protein, or to identify regions of the protein which interact with another molecule.

### Claim 6 (depends on 1)

The method of claim 1, wherein NMR spectroscopic analysis of the protein is used to determine information about the three dimensional structure, the conformational state, the aggregation level, or the state of unfolding of the protein.

### Claim 7 (depends on 1)

The method of claim 1, wherein NMR spectroscopic analysis involves 1D NMR, 2D NMR or 15N/1H correlation spectroscopy.

### Claim 8 (depends on 1)

The method of claim 1, wherein x-ray diffraction is used to determine the three dimensional structure of the protein.

### Claim 9 (depends on 1)

The method of claim 1, wherein the protein comprises one or more labels so as to facilitate structural characterization of the protein.

### Claim 10 (depends on 9)

The method of claim 9, wherein the protein comprises an isotopic label.

### Claim 11 (depends on 10)

The method of claim 10, wherein the isotopic label is one of the following: potassium-40 (40K), carbon-14 (14C), tritium (3H), sulphur-35 (35S), phosphorus-32 (32P), technetium-99m (99mTc), thallium-201 (201Tl), gallium-67 (67Ga), indium-111 (111In), iodine-123 (123I), iodine-131 (131I), yttrium-90 (90Y), samarium-153 (153Sm), rhenium-186 (186Re), rhenium-188 (188Re), dysprosium-165 (165Dy), holmium-166 (166Ho), hydrogen-1 (1H), hydrogen-2 (2H), hydrogen-3 (3H), phosphorous-31 (3P), sodium-23 (23Na), nitrogen-14 (14N), nitrogen-15 (15N), carbon-13 (13C) and fluorine-19 (19F).

### Claim 12 (depends on 10)

The method of claim 10, wherein the protein comprises at least two different isotopic labels.

### Claim 13 (depends on 12)

The method of claim 12, wherein the protein comprises at least one 15N label and at least one 13C label.

### Claim 14 (depends on 9)

The method of claim 9, wherein the protein comprises a heavy atom label.

### Claim 15 (depends on 14)

The method of claim 14, wherein the heavy atom label is one of the following: cobalt, selenium, krypton, bromine, strontium, molybdenum, ruthenium, rhodium, palladium, silver, cadmium, tin, iodine, xenon, barium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, tantalum, tungsten, rhenium, osmium, iridium, platinum, gold, mercury, thallium, lead, thorium and uranium.

### Claim 16 (depends on 9)

The method of claim 9, wherein the protein comprises at least one seleno-methionine.

### Claim 17 (depends on 9)

The method of claim 9, wherein the protein comprises at least one isotopic label and at least on heavy atom label.

### Claim 18 (depends on 1)

The method of claim 1, which further comprises identifying a site on the protein that a compound is expected to bind.

### Claim 19 (depends on 18)

The method of claim 18, wherein the site is a location on the three dimensional structure comprising three or more amino acid residues of the protein.

### Claim 20 (depends on 18)

The method of claim 18, wherein the site is identified by comparing structural information of the protein obtained in the presence and absence of a compound.

### Claim 21 (depends on 20)

The method of claim 20, wherein the test compound is a polypeptide, nucleic acid, or small molecule.

### Claim 22 (depends on 1)

The method of claim 1, which further comprises characterizing the ability of a compound to interact with the three dimensional structure of the protein using a computational method.

### Claim 23 (depends on 22)

The method of claim 22, which further comprises determining the ability of the compound to bind to the protein using an activity assay, wherein a change in the activity of the protein in the presence of the test compound indicates that the test compound binds to the three dimensional structure of the protein.

### Claim 24 (depends on 1)

A computer readable storage medium comprising digitally encoded structural data, wherein the data comprise the identity of a protein and the three dimensional structure information of the protein obtained using the method of claim 1.

### Claim 25 (depends on 1)

A database comprising the identity of a protein and the three dimensional structure information of the protein obtained using the method of claim 1.

### Claim 26 (depends on 1)

The method of claim 1, wherein the protein is a member of a library of proteins.

### Claim 27 (depends on 1)

The method of claim 1, wherein one or more of the analyses is automated.

### Claim 28 (depends on 1)

The method of claim 1, wherein the protein is at least about 80% pure by weight.

### Claim 29 (depends on 1)

The method of claim 1, wherein the protein is at least about 70% soluble as measured by light scattering.

### Claim 30 (depends on 1)

The method of claim 1, wherein the protein is fused to at least one heterologous polypeptide.

### Claim 31 (depends on 1)

The method of claim 1, wherein the protein diffracts x-rays to a resolution of about 3.5 Åor better.
